Background: Dimethyl fumarate is an oral treatment for multiple sclerosis, whose mechanism of action is not fully understood.
Objective: To investigate the effects of dimethyl fumarate on DNA methylation in the CD4 T cells of multiple sclerosis patients.
Methods: We performed Illumina EPIC arrays to investigate the DNA methylation profiles of CD4 T cells derived from multiple sclerosis patients before and after dimethyl fumarate treatment.
Results: Treatment with dimethyl fumarate resulted in 97% of differentially methylated positions showing hypermethylation. Four genes, , , and had a differentially methylated region located within the transcriptional start site.
Conclusion: This study investigates the effect of dimethyl fumarate on DNA methylation in multiple sclerosis patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050818 | PMC |
http://dx.doi.org/10.1177/2055217318787826 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!